CVE-2026-26890
Sourcecodester Pharmacy Point of Sale System v1.0 is vulnerable to SQL Injection in /pharmacy...
Sourcecodester Pharmacy Point of Sale System v1.0 is vulnerable to SQL Injection in /pharmacy/manage_product.php.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- High
- User interaction
- None
What an attacker can affect
- Confidentiality
- Low
- Integrity
- None
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
Sourcecodester Pharmacy Point of Sale System v1.0 is vulnerable to SQL Injection in /pharmacy/manage_product.php.
- Record
CVE-2026-26890- CVSS 3.1
- 2.7 Low
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:N/A:N - Weakness
- CWE-89
- Updated
- 2026-11-02
EUVDEUVD-2026-9307
Sourcecodester Pharmacy Point of Sale System v1.0 is vulnerable to SQL Injection in /pharmacy/manage_product.php.
- Record
EUVD-2026-9307- CVSS 3.1
- 2.7 Low
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:N/A:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-phgx-m9w4-2pw4
Sourcecodester Pharmacy Point of Sale System v1.0 is vulnerable to SQL Injection in /pharmacy...
Sourcecodester Pharmacy Point of Sale System v1.0 is vulnerable to SQL Injection in /pharmacy/manage_product.php.
- Record
GHSA-phgx-m9w4-2pw4- CVSS 3.1
- 2.7 Low
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:N/A:N - Weakness
- CWE-89
- Updated
- 2026-11-02
NVD
Sourcecodester Pharmacy Point of Sale System v1.0 is vulnerable to SQL Injection in /pharmacy/manage_product.php.
- Record
CVE-2026-26890- CVSS 3.1
- 2.7 Low
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:N/A:N - Weakness
- CWE-89
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2026-26890 is a low vulnerability (CVSS 2.7) in Oretnom23 Pharmacy Point Of Sale System, published March 3, 2026. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.32%, the 25th percentile. No source names a fixed version.